KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Long-Term Investments (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Long-Term Investments for 9 consecutive years, with $995000.0 as the latest value for Q1 2025.

  • On a quarterly basis, Long-Term Investments fell 80.37% to $995000.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $995000.0, a 80.37% decrease, with the full-year FY2024 number at $995000.0, down 80.37% from a year prior.
  • Long-Term Investments was $995000.0 for Q1 2025 at Biolife Solutions, roughly flat from $995000.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $5.1 million in Q4 2022 to a low of $995000.0 in Q2 2024.
  • A 4-year average of $3.3 million and a median of $5.1 million in 2022 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: changed 0.0% in 2023, then tumbled 80.37% in 2024.
  • Biolife Solutions' Long-Term Investments stood at $5.1 million in 2022, then changed by 0.0% to $5.1 million in 2023, then crashed by 80.37% to $995000.0 in 2024, then changed by 0.0% to $995000.0 in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Long-Term Investments are $995000.0 (Q1 2025), $995000.0 (Q4 2024), and $995000.0 (Q3 2024).